Collaborative Drug Discovery at UC San Diego
UCSD Researchers Drs. Douglas Galasko and Steven L. Wagner will head a new multi-institutional NIH planning grant, "Translational Center for Alzheimer's Disease Target and Drug Discovery". This planning project brings together leading researchers from Salk, SBRI, TSRI, and UCSD.
Drs. Rommie Amaro, Victoria Feher and Michael Gilson will develop a new Drug Design Data Resource (D3R) which will connect industrial and academic groups to advance computer-aided drug discovery technologies, through improved access to protein-small molecule interaction data and effective molecular modeling workflows, coupled with community-wide prediction exercises. This project is funded by a five year, $3.7M NIH grant.
Harnessing Science to Create New Cures
- A revolutionary drug discovered in seaweed growing naturally off the California coast gives new hope to cancer patients.
- A graduate student brings the power of a supercomputer to bear on the design of new medications for deadly tropical diseases.
- A scientist uncovers a single, key molecular pathway involved in heart diseases, lupus, and certain cancers, and thus establishes the groundwork for new preventive therapies.
Scenarios like these are not far from reality. Researchers at UC San Diego are constantly working to create new medications to treat life-threatening diseases such as cancer and malaria, and to identify more effective treatments for conditions such as lupus, where existing treatments only address symptoms.